2. Schuck E, Bohnert T, Chakravarty A, Damian-Iordache V, Gibson C, Hsu CP, et al. Preclinical pharmacokinetic/pharmacodynamic modeling and simulation in the pharmaceutical industry: an IQ consortium survey examining the current landscape. AAPS J. 2015; 17:462–473. DOI:
10.1208/s12248-014-9716-2. PMID:
25630504.
Article
3. Chein JY, Friedrich S, Heathman MA, de Alwis DP, Sinha V. Pharmacokinetics/pharmacodynamics and the stages of drug development: role of modeling and simulation. AAPS J. 2005; 7:E544–E559. DOI:
10.1208/aapsj070355. PMID:
16353932.
Article
4. Lee M, Choi M. Analysis on time-lag effect of research and development investment in the pharmaceutical industry in Korea. Osong Public Health Res Perspect. 2015; 6:241–248. DOI:
10.1016/j.phrp.2015.07.001. PMID:
26473091.
Article